welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
- log in
Pediatric Radio Frequency Coils Generic
study id #: NCT01633866
condition: Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities
status: active, not recruitingpurpose:
The purpose of this study is to evaluate and optimize advances in radio frequency (RF) coil magnetic resonance imaging (MRI) technology at Cincinnati Children’s Hospital Medical Center (CCHMC).
mechanism of action: No pharmaceutical intervention
last updated: February 14, 2020
start date: July 2012
estimated completion: June 2022
size / enrollment: 75
Pediatric Magnetic resonance (MR) imaging techniques have been limited by the unavailability of specialized radio-frequency (RF) coils for pediatric imaging. Typically, MR coils are designed for general purpose adult imaging and lack the mechanical design, flexibility and high channel count needed for pediatric imaging. Furthermore, pediatric patients are often positioned decubitus or prone rather than supine. This makes coil positioning even more challenging and often results in images with low SNR and poor image quality. Many coils used in clinical practice have fixed dimensions that do not fit within the realm of "one-size fits all," especially for the huge variation found in the pediatric patient population.
MRI coil development and optimization is performed by MR manufacturers and in research laboratories across the world including the Imaging Research Center (IRC) of Cincinnati Children's Hospital and Medical Center (CCHMC). Coil development and refinement involves evaluating the new coils on inert phantoms and then imaging examinations performed on healthy participants and patients. The focus of this study protocol is to evaluate the design and performance of investigational coils on patients and healthy participants.
- Number of participants with adverse events as measured by heating and comfort participant response [ Time Frame: Day 1 ]
- MRI Image Quality [ Time Frame: 2 Weeks Post MRI Scan ]
• Male or Female
• Thermally stable
• Any age
• Male or Female
• Thermally stable
• any age
Healthy participants & Clinical patients
• Female participants who are pregnant or lactating
• Subjects with standard contraindications to MRI
CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic CarriersThis is an investigation of the efficacy...
Virtual Reality in Individuals With Duchenne Muscular DystrophyWith the growing accessibility of comput...
Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business UpdateSolid Biosciences Inc. today reported fi...
CoQ10 and Prednisone in Non-Ambulatory DMDThis study will help determine if CoQ10 ...
Rimeporide in Patients With Duchenne Muscular DystrophyIn Duchenne Muscular Dystrophy (DMD) the...
Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)The objective of this study is to assess...
L-citrulline and Metformin in Duchenne’s Muscular DystrophyThe purpose of the study is to show that...
Capricor trial failure in heart disease might offer another opportunityOn Friday Capricor Therapeutics announce...
Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical TrialCapricor Therapeutics announced today th...
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, ran...Background: Duchenne muscular dystrophy...
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Puldysa® (Idebenone) in D...Santhera Pharmaceuticals announces that ...